UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1

CUSIP: 91307CAF9

Q3 2014 13F Holders as of 30 Sep 2014

Type / Class
Debt / NOTE 1.000% 9/1
Market price (% of par)
269.24%
Total 13F principal
$239,870,400
Principal change
+$23,325,000
Total reported market value
$646,058,860
Number of holders
20
Value change
+$66,870,578
Number of buys
7
Number of sells
9

Quarterly Holders Quick Answers

What is CUSIP 91307CAF9?
CUSIP 91307CAF9 identifies 91307CAF9 - UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 as of Q3 2014

As of 30 Sep 2014, UNITED THERAPEUTICS CORP DEL - NOTE 1.000% 9/1 was held by 20 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $239,870,400 in principal (par value) of the bond. The largest 10 bondholders included Castle Creek Arbitrage, LLC, WOLVERINE ASSET MANAGEMENT LLC, CAMDEN ASSET MANAGEMENT L P /CA, Citadel Advisors LLC, QVT Financial LP, BASSO CAPITAL MANAGEMENT L.P., WHITEBOX ADVISORS LLC, BlueMountain Capital Management, LLC, LAZARD ASSET MANAGEMENT LLC, and Jefferies Group LLC. This page lists 20 institutional bondholders reporting positions for the Q3 2014 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.